InvestorsHub Logo
Followers 6
Posts 292
Boards Moderated 0
Alias Born 09/27/2018

Re: sts66 post# 326444

Tuesday, 02/23/2021 8:42:49 PM

Tuesday, February 23, 2021 8:42:49 PM

Post# of 423591
We need the FDA to remove gL as an option like they did with Niaspan and fenofibrate.

https://www.tctmd.com/news/no-more-niacin-fibrate-combinations-statins-fda

If there is no proven CV benefit with the other TG lowering drugs with statins then we are wasting $ on those drugs and wr pay for the costly downstream events.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News